Navigation Links
February 2009 Mayo Clinic Women's HealthSource Highlights Diabetes and Heart Disease, Going Vegetarian and Tinnitus
Date:2/4/2009

s the glycoslyated hemoglobin A1C test. This blood test, given by a physician, reflects average blood sugar control over three months. The ADA recommends maintaining the A1C level at less than 7 percent. New research has indicated that intensive measures required to get below 7 percent might not offer cardiovascular benefits. A physician can determine the best goal for the A1C level. The test is recommended at least twice a year.

Blood pressure: High blood pressure is a common partner to diabetes. For people with diabetes, an ideal reading is below 130/80 millimeters of mercury (mm Hg).

Cholesterol levels: The optimal target is less than 100 milligrams per deciliter (mg/dL) for low-density lipoprotein (LDL) cholesterol. For high-density lipoprotein (HDL) cholesterol, the recommended level is more than 50 mg/dL for women and more than 40 mg/dL for men.

A physician can help with a treatment plan to meet these guidelines. A healthy diet, regular physical activity, weight loss, smoking cessation and limited alcohol consumption all are beneficial. Medications also may be needed. For example, research has shown that most adults with high blood pressure and diabetes require multiple drug therapies to reach blood pressure goals.

The bottom line: Risks and complications from diabetes and heart disease are intertwined. People with diabetes who manage heart disease risks can help avoid life-threatening complications.

Going Vegetarian? With A Little Planning, It's Easier than Ever

ROCHESTER, Minn. --- There's more to being a vegetarian than cutting meat from the menu. The February issue of Mayo Clinic Women's HealthSource offers suggestions for a well-balanced vegetarian diet --- and some reasons why it's worth considering.

The vegetarian menu emphasizes the food that U.S. dietary guidelines say all Americans should eat regula
'/>"/>

SOURCE Mayo Clinic
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference
2. InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
8. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
9. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
10. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
11. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... y LONDRES, August 29, 2015 ... para los sistemas de imagen por Ultrasonidos ... Ecografía, tiempos de examen rápidos y un flujo de ... confianza diagnóstica en el proceso de detección de Cardiopatías ... PHIA) ha anunciado hoy el lanzamiento europeo de ...
(Date:8/28/2015)... According to a new market ... Prostate) Type (Protein & Genetic Biomarkers) Profiling Technology (Proteomics, ... Geography - Global Forecast to 2020", published by MarketsandMarkets, ... 17,689.0 Million USD by 2020 at a CAGR of ... Browse 191 Tables and 38 F ...
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on China,s ... Tobramycin is a traditional antibiotic whose eye drop ... the treatment of potential infection or inflammation caused by ... China are able to produce tobramycin, among ...
Breaking Medicine Technology:Philips presenta HeartModel A.I en el Congreso ESC 2015 2Philips presenta HeartModel A.I en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 4Philips presenta HeartModel A.I en el Congreso ESC 2015 5Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5Investigation Report on China's Tobramycin Market, 2015-2019 2
... NEW YORK, Sept. 27 Keryx Biopharmaceuticals, Inc. (Nasdaq: ... Chief Executive Officer, will be presenting at the JMP Securities ... in New York City.  Mr. Bentsur,s presentation is scheduled to ... A live audio webcast of Mr. Bentsur,s presentation ...
... Mass., Sept. 25 Boston Scientific Corporation (NYSE: ... data from the HORIZONS-AMI trial.  The trial, sponsored ... support from Boston Scientific and The Medicines Company ... determine the safety and efficacy of the TAXUS® ...
Cached Medicine Technology:Keryx Biopharmaceuticals to Present at JMP Securities Healthcare Conference 2HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack Patients 2HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack Patients 3HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack Patients 4
(Date:8/31/2015)... ... , ... “My mother and husband use oxygen therapy and the tubing irritates ... could be a comfortable way to prevent the irritation, so I invented this.” She ... more secure way to anchor the cannula tubing used in oxygen therapy and it ...
(Date:8/31/2015)... ... August 31, 2015 , ... A year ago this month, Seniors Guide ... release a new issue commemorating the successful first year. , “We started the ... potentially difficult time in their lives,” says Melissa Wolfert, founding Publisher for Seniors Guide ...
(Date:8/31/2015)... ... ... There’s big news for ZendyHealth , a Los Angeles-based startup company ... health plans (CDHPs) are a growing phenomenon, and ZendyHealth has brought on two experts ... another to answer customers’ questions directly. , John Young, CEO of Consumerdriven, LLC will ...
(Date:8/31/2015)... Georgia (PRWEB) , ... August 31, 2015 , ... ... the Eco Commerce Exchange and Organization Supporting Business Owners and provided a tour ... in Atlanta, Georgia, represents the success possible to international companies expanding business in ...
(Date:8/31/2015)... ... August 31, 2015 , ... On Saturday, July 11, 2015, ... Center in New York City, NYSATA was proud to recognize Dr. Merritt F. Spear ... Scriber Recognition Award, named after long-time NYSATA member and Ithaca College athletic trainer ...
Breaking Medicine News(10 mins):Health News:InventHelp® Inventor Designs Nasal Cannula Ear Protector (AVZ-1217) 2Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 2Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 3Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 2Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 3Health News:PartnerTech Supports Economic Growth as Host 2Health News:NYS Athletic Trainers' Association Presents Recognition Awards at Annual Conference 2Health News:NYS Athletic Trainers' Association Presents Recognition Awards at Annual Conference 3
... ... ... ... ...
... -- (March 5, 2010) Components of the blood or ... single stem cell that gives rise to all the different ... of Medicine ( www.bcm.edu ) in a report that appears ... Cell ( www.cell.com/cell-stem-cell/ ) "While previous ...
... Cholangiocarcinoma (CCA), a bile duct cancer, is one of ... difficult to diagnose and has high metastatic and mortality ... receptor, has frequently been found in CCA and is ... activation induces a variety of cellular processes, including cell ...
... Calculus Bovis compound preparation (ICCBco) in the treatment ... schistosomiasis as the experimental animal model, a research ... trial to observe pathological changes and pathological effect ... the lung tissue of portal hypertensive rabbits with ...
... ... to let tax season negatively affect their personal credit report , ... Delray Beach, FL (PRWEB) March 4, 2010 -- NationalCreditReport.com, ... help consumers improve their credit scores. Although the tax filing deadline is drawing near, there ...
... appears to combat mesothelioma tumors , THURSDAY, March 4 ... cancer mesothelioma is safe, according to a new study. ... which infuses a patient,s own dendritic cells with antigen ... found that it induced an immune T-cell response against ...
Cached Medicine News:Health News:Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus 2Health News:Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus 3Health News:Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus 4Health News:Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus 5Health News:Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus 6Health News:Theory of single stem cell for blood components challenged 2Health News:Different signaling pathways of cholangiocarcinoma 2Health News:Treatment of portal hypertensive pulmonary lesions induced by schistosomiasis 2Health News:NationalCreditReport.com Offers Simple Tax Saving Tips That Can Improve Credit Scores 2Health News:NationalCreditReport.com Offers Simple Tax Saving Tips That Can Improve Credit Scores 3Health News:Vaccine for Asbestos-Related Cancer Looks Safe 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: